1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Gynaecological conditions
  5. Menopause

Menopause: identification and management

NICE guideline [NG23] Published: 12 November 2015 Last updated: 07 November 2024

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Research recommendation(s) from an individual piece of guidance

Guidance:
Menopause: identification and management
Date issued:
12 November 2015

Research recommendations coming out of this guidance

  • Women with breast cancer:- What is the safety and effectiveness of alternatives to systemic HRT as treatments for menopausal symptoms in women who have had treatment for breast cancer?

  • Effects of HRT on breast cancer risk:- What is the difference in the risk of breast cancer in menopausal women on HRT with progesterone, progestogen or selective oestrogen receptor modulators?

  • Effects of HRT on venous thromboembolism risk:- How does the preparation of HRT affect the risk of venous thromboembolism (VTE)?

  • Effects of HRT on dementia risk:- What are the effects of early HRT use on the risk of dementia?

  • Premature ovarian insufficiency:- What are the main clinical manifestations of premature ovarian insufficiency and the short- and long-term impact of the most common therapeutic interventions?